Cite

HARVARD Citation

    Miura, Y. et al. (2020). Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events. Thoracic cancer. 11 (5), pp. 1280-1287. [Online]. 
  
Back to record